Ignite Creation Date:
2024-07-17 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06485245
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-26
Brief Title:
Study to Evaluate Safety Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects
Sponsor:
Cascade Pharmaceuticals Inc
Organization:
Cascade Pharmaceuticals Inc
Study Overview
Official Title:
A Phase I Study Evaluating the Safety Tolerability Pharmacokinetics and Food Effect of Randomized Double-Blind Placebo-Controlled Single and Multiple Dose Escalations of CS060304 in Healthy and Elevated LDL-C Subjects
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study to Evaluate Safety Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects
Detailed Description:
A Phase I study Evaluating the Safety Tolerability Pharmacokinetics and Food Effects of Randomised Double-Blind Placebo-Controlled Single and Multiple Dose Escalations of CS060304 in Healthy and Elevated LDL-C Subjects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None